
Sunday, July 31, 2022 3:30:19 PM
It's becoming a joke. That said, no doubt a BO of ADMP happens tomorrow based on what I am seeing on 1 minute chart and ADMP's correlation to the home builders index.
Rolling Stones are old and they suck!

Liked By
Spread the love. Be the first to like this post!
Recent ADMP News
- Additional Proxy Soliciting Materials (definitive) (defa14a) • Edgar (US Regulatory) • 03/17/2023 12:09:24 PM
- Current Report Filing (8-k) • Edgar (US Regulatory) • 03/17/2023 12:07:50 PM
- Adamis Pharmaceuticals Reports Full Year 2022 Financial Results and Provides Corporate Update • GlobeNewswire Inc. • 03/16/2023 08:24:01 PM
- Annual Report (10-k) • Edgar (US Regulatory) • 03/16/2023 07:59:02 PM
- Current Report Filing (8-k) • Edgar (US Regulatory) • 03/14/2023 09:26:36 PM
- Adamis Pharmaceuticals Schedules Fourth Quarter and Full Year 2022 Financial Results Conference Call and Corporate Update • GlobeNewswire Inc. • 03/14/2023 08:01:00 PM
- Adamis Pharmaceuticals Announces $3.0 Million Registered Direct Offering • GlobeNewswire Inc. • 03/14/2023 12:30:00 PM
- Adamis Pharmaceuticals and DMK Pharmaceuticals Announce Agreement and Plan of Merger • GlobeNewswire Inc. • 02/27/2023 09:05:00 PM
- Current Report Filing (8-k) • Edgar (US Regulatory) • 02/23/2023 12:09:13 PM
- Nasdaq Grants Adamis Pharmaceuticals’ Request for Extension to Comply with Continued Listing Requirements • GlobeNewswire Inc. • 02/22/2023 09:01:00 PM
- Quarterly Report (10-q) • Edgar (US Regulatory) • 11/14/2022 09:59:00 PM
- Current Report Filing (8-k) • Edgar (US Regulatory) • 11/14/2022 09:48:05 PM
- Adamis Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Corporate Update • GlobeNewswire Inc. • 11/14/2022 09:10:07 PM
- Adamis Pharmaceuticals Schedules Third Quarter 2022 Financial Results Conference Call and Corporate Update • GlobeNewswire Inc. • 11/07/2022 09:05:00 PM
- Current Report Filing (8-k) • Edgar (US Regulatory) • 10/04/2022 10:16:15 AM
- Current Report Filing (8-k) • Edgar (US Regulatory) • 10/04/2022 10:09:16 AM
- Adamis Announces Review of Strategic Alternatives • GlobeNewswire Inc. • 10/03/2022 08:30:00 PM
- Current Report Filing (8-k) • Edgar (US Regulatory) • 09/23/2022 09:08:52 PM
- Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) • Edgar (US Regulatory) • 09/23/2022 09:06:45 PM
- Adamis Provides Update on the Phase 2/3 Trial of Tempol in COVID-19 Positive High-Risk Subjects • GlobeNewswire Inc. • 09/21/2022 11:30:00 AM
- Notice of Effectiveness (effect) • Edgar (US Regulatory) • 09/20/2022 10:03:49 AM
- Adamis Provides an Enrollment Update on the Phase 2/3 Study of Tempol in COVID-19 Positive High-Risk Subjects • GlobeNewswire Inc. • 09/12/2022 08:05:00 PM
- Current Report Filing (8-k) • Edgar (US Regulatory) • 09/12/2022 10:05:18 AM
- Securities Registration Statement (simplified Form) (s-3) • Edgar (US Regulatory) • 09/09/2022 09:13:00 PM
- Additional Proxy Soliciting Materials (definitive) (defa14a) • Edgar (US Regulatory) • 08/18/2022 07:09:02 PM
FEATURED Fineqia's EEA Unit Receives Approval of Base Prospectus for Issuing Exchange Traded Notes (ETNs) • Mar 28, 2023 9:37 AM
FEATURED Usha Resources Enters Hard-Rock Lithium Space with Acquisition of Significant Ontario Land Package with Highly Evolved LCT-Pegmatites • Mar 28, 2023 8:26 AM
FEATURED Edison Lithium Provides Update on Spin-Out of Cobalt Assets • Mar 28, 2023 8:09 AM
PSYC's CEO to Moderate Panel at Film Screening for ESPN's Upcoming Documentary, "Peace of Mind" • PSYC • Mar 29, 2023 8:30 AM
Epazz Holdings: ZenaDrone, Inc. 1000 AI Predictive Received a Letter of Support from the US Airforce for Drone Cargo Delivery and Intent to Use ZenaDrone 1000 Platform • EPAZ • Mar 28, 2023 7:11 AM
Metatron Releases All-in-One Artificial Intelligence Mobile Apps for iPhone and Android • MRNJ • Mar 27, 2023 9:00 AM